1. Home
  2. UNCY vs GGR Comparison

UNCY vs GGR Comparison

Compare UNCY & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • GGR
  • Stock Information
  • Founded
  • UNCY 2016
  • GGR 2011
  • Country
  • UNCY United States
  • GGR Taiwan
  • Employees
  • UNCY N/A
  • GGR N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • GGR Auto Manufacturing
  • Sector
  • UNCY Health Care
  • GGR Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • GGR Nasdaq
  • Market Cap
  • UNCY 74.2M
  • GGR 88.6M
  • IPO Year
  • UNCY 2021
  • GGR N/A
  • Fundamental
  • Price
  • UNCY $4.63
  • GGR $5.80
  • Analyst Decision
  • UNCY Strong Buy
  • GGR Hold
  • Analyst Count
  • UNCY 5
  • GGR 2
  • Target Price
  • UNCY $55.20
  • GGR $10.00
  • AVG Volume (30 Days)
  • UNCY 510.5K
  • GGR 28.9K
  • Earning Date
  • UNCY 11-12-2025
  • GGR 11-13-2025
  • Dividend Yield
  • UNCY N/A
  • GGR N/A
  • EPS Growth
  • UNCY N/A
  • GGR N/A
  • EPS
  • UNCY N/A
  • GGR N/A
  • Revenue
  • UNCY N/A
  • GGR $289,420,000.00
  • Revenue This Year
  • UNCY N/A
  • GGR N/A
  • Revenue Next Year
  • UNCY $4,481.14
  • GGR $5.00
  • P/E Ratio
  • UNCY N/A
  • GGR N/A
  • Revenue Growth
  • UNCY N/A
  • GGR N/A
  • 52 Week Low
  • UNCY $3.40
  • GGR $3.76
  • 52 Week High
  • UNCY $11.00
  • GGR $15.00
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 61.71
  • GGR 94.47
  • Support Level
  • UNCY $3.72
  • GGR $0.29
  • Resistance Level
  • UNCY $4.80
  • GGR $6.21
  • Average True Range (ATR)
  • UNCY 0.24
  • GGR 0.08
  • MACD
  • UNCY 0.07
  • GGR 0.57
  • Stochastic Oscillator
  • UNCY 75.00
  • GGR 95.42

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: